AMPD1: a novel therapeutic target for reversing insulin resistance

BACKGROUND: Insulin resistance is one of the hallmark manifestations of obesity and Type II diabetes and reversal of this pathogenic abnormality is an attractive target for new therapies for Type II diabetes. A recent report that metformin, a drug known to reverse insulin resistance, demonstrated in...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Endocr Disord
Päätekijät: Cheng, Jidong, Morisaki, Hiroko, Toyama, Keiko, Sugimoto, Naomi, Shintani, Takuya, Tandelilin, Andreas, Hirase, Tetsuaki, Holmes, Edward W, Morisaki, Takayuki
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2014
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4274759/
https://ncbi.nlm.nih.gov/pubmed/25511531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6823-14-96
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia